DUNKIRK, NY (Marketwire – Jun 29, 2011) – Cott Beverages Inc., a subsidiary of Cott Corporation (NYSE: COT) (TSX: BCB), the world’s largest private label beverage company, announced today that its Star PhytoNutrients division has licensed patents owned by Rutgers University from Gencor Nutrients Inc. U.S. patent numbers 6,608,102 and 6,720,353 cover among other things, the use of certain Cranberry extracts for urinary tract health and support, in products such as dietary supplements, functional foods and beverages.
The Rutgers patents focus on the antimicrobial effect of bacterial adhesion prevention associated with phytonutrients found in Cranberry fruit and juice.
“We are extremely pleased to be associated with the important work done at Rutgers University,” said Doug Lynch, VP, Business Development of the Star PhytoNutrients Division of Cott Beverages Inc. “It once again emphasizes the commitment that we make to all of our customers: we provide our customers with access to the best in class research, intellectual property, marketing support, and demonstrable efficacy, associated with our botanical ingredients and services.”
Urinary Tract Infections are extremely common and lead to approximately seven million doctor visits, one million emergency room visits, and one hundred thousand hospitalizations annually, according to a report from the NIH.
For years, cranberries have been associated with maintenance of urinary tract health, but the mechanism was thought to be due to the acidity of the fruit. The Rutgers team isolated and identified a type of condensed tannin called proanthocyanidin (PAC) from cranberries that prevents certain bacteria in the urinary tract, stomach and mouth from adhering to cells in the body. The Rutgers group discovered that this bacterial anti-adhesion effect was unique to cranberries and may be due to the presence of unusual “A-type” bonds found in their PAC molecules. Rutgers researchers have been able to isolate these Cranberry PACs from the most highly concentrated sources, resulting in a product with high potency, stability and efficacy.
According to patent co-inventor Dr. Amy B. Howell, “These natural PACs with A-type bonds found in cranberries have the ability to keep certain bacteria from sticking to cells. This inhibits the bacteria from growing and causing infection.” Dr. Howell continued, “Unlike antibiotics, the PACs don’t kill the bacteria so there is no build-up of bacterial-resistant populations. They work in a natural way to prevent bacterial adhesion.”
Patent inventors Amy B. Howell, Ph.D. and Nicholi Vorsa, Ph.D. are both from the Rutgers University Marucci Blueberry and Cranberry Research and Extension Center. Dr. Howell, an Associate Research Scientist at the Center, and Dr. Vorsa, the Center Director, have spent many years researching Cranberry PACs. Their findings have been published in multiple scholarly journals including The New England Journal of Medicine, Phytochemistry and The Journal of the American Medical Association.
About Star PhytoNutrients
The Star PhytoNutrients division of Cott Beverages Inc., a subsidiary of Cott Corporation, develops and markets value-added botanical, fruit, antioxidant and highly functional ingredients, specializing in juice concentrates, fruit powders, and fruit extracts for use in food, beverages, nutraceuticals and cosmeceuticals. With a full line of ingredients derived from cranberries, the number one botanical ingredient in North America, Star PhytoNutrients has developed proprietary technologies for enhanced product functionality. For more information, please contact Douglas Lynch or Richard Star at 716-366-6100, or visit www.cott.com.